Healthcare Triangle, Inc.
HCTI
$2.41
$0.051.90%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 213.95% | -10.03% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 213.95% | -10.03% | |||
| Cost of Revenue | 177.29% | -6.27% | |||
| Gross Profit | 434.15% | -27.51% | |||
| SG&A Expenses | 28.60% | 28.99% | |||
| Depreciation & Amortization | 28.57% | 900.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 77.76% | 24.70% | |||
| Operating Income | 18.46% | -71.48% | |||
| Income Before Tax | -37.64% | -136.25% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -37.64% | -136.25% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -37.64% | -136.25% | |||
| EBIT | 18.46% | -71.48% | |||
| EBITDA | 20.88% | -50.83% | |||
| EPS Basic | 79.78% | -27.98% | |||
| Normalized Basic EPS | 87.83% | -29.15% | |||
| EPS Diluted | 79.78% | -27.98% | |||
| Normalized Diluted EPS | 87.83% | -29.15% | |||
| Average Basic Shares Outstanding | 580.83% | 84.48% | |||
| Average Diluted Shares Outstanding | 580.83% | 84.48% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||